NI
BPMC

Numeric Investors’s Blueprint Medicines BPMC Stock Holding History

Numeric Investors’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-19,100
Closed -$1.33M – 1065
2017
Q3 		$1.33M Sell
19,100
-221,771
-92% -$11.9M 0.01% 691
2017
Q2 		$12.2M Buy
+240,871
New +$10.2M 0.11% 196

Other funds holding BPMC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

Numeric Investors's BPMC Position: Q4 2017 in Review

Numeric Investors sold out of Blueprint Medicines (BPMC) in Q4 2017, closing a stake of 19,100 shares — an estimated $1.33M sold.

Numeric Investors first reported a position in BPMC in Q2 2017 and held it in 2 quarters. The position peaked at $12.2M in Q2 2017. 170 funds tracked by Wall St. Rank hold BPMC as of Q4 2017.

  • Numeric Investors reported no remaining Blueprint Medicines position as of Q4 2017 after selling out during the quarter.
  • Numeric Investors sold 19,100 Blueprint Medicines shares in Q4 2017, an estimated $1.33M.
  • Numeric Investors first reported a position in Blueprint Medicines in Q2 2017 and held it in 2 quarters.
  • Numeric Investors's Blueprint Medicines position peaked at $12.2M in Q2 2017.
  • 170 funds tracked by Wall St. Rank held Blueprint Medicines as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.